Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 14/20 | 0.42 |
| ▸ | XIAP | P98170 | 2/20 | 0.40 |
| ▸ | CMA1 | P23946 | 3/20 | 0.38 |
| ▸ | MLX | Q9UH92 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8662040 | 0.97 | ELANE (0.40) | ELANEXIAPCMA1MLX | |
| SCHEMBL228960 | 0.90 | ELANE (0.38) | ELANEXIAPCMA1MLX | |
| SCHEMBL5487413 | 0.90 | ELANE (0.38) | ELANEXIAPCMA1MLX | |
| SCHEMBL3276266 | 0.88 | ELANE (0.42) | ELANEXIAPCMA1MLX | |
| SCHEMBL535732 | 0.88 | ACE (0.40) | — | |
| SCHEMBL230923 | 0.85 | ELANE (0.33) | ELANECMA1 | |
| SCHEMBL5494650 | 0.85 | ELANE (0.40) | ELANEXIAPCMA1MLX | |
| SCHEMBL847832 | 0.84 | CMA1 (0.49) | XIAPCMA1 | |
| SCHEMBL387694 | 0.83 | TACR1 (0.40) | ELANEXIAPCMA1MLX | |
| SCHEMBL8661389 | 0.81 | ELANE (0.36) | ELANECMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0964690-B1 | PEPTIDE-LIPID CONJUGATES, LIPOSOMES AND LIPOSOMAL DRUG DELIVERY | LIPOSOME CO INC (US) | 2003-07-09 | — | — | EP | claimed |
| US-6143716-A | CONTROLLED DELIVERY SYSTEM TO DELIVER LIPOSOMAL DRUGS IN VITRO OR IN VIVO, FOR EXAMPLE, IN TREATMENT OF MAMMALS AFFLICTED WITH VARIOUS DISEASES, DISORDERS OR CONDITIONS, E.G., CANCERS | THE LIPOSOME COMPANY, INC. (US) | 2000-11-07 | — | — | US | claimed |
| US-6087325-A | CONJUGATE OF CERTAIN PEPTIDES TO PHOSPHATIDYLETHANOLAMINES, INCORPORATED INTO LIPOSOMES SO AS TO SELECTIVELY DESTABILIZE THE LIPOSOMES IN THE VICINITY OF TARGET PEPTIDASE-SECRETING CELLS, HENCE DELIVER THE LIPOSOMES | THE LIPOSOME COMPANY, INC. (US) | 2000-07-11 | — | — | US | claimed |
| EP-0964690-A4 | PEPTIDE-LIPID CONJUGATES, LIPOSOMES AND LIPOSOMAL DRUG DELIVERY | LIPOSOME CO INC (US) | 2000-03-29 | — | — | EP | claimed |
| EP-0964690-A1 | PEPTIDE-LIPID CONJUGATES, LIPOSOMES AND LIPOSOMAL DRUG DELIVERY | THE LIPOSOME COMPANY, INC. (US) | 1999-12-22 | — | — | EP | claimed |
| WO-1998016240-A1 | PEPTIDE-LIPID CONJUGATES, LIPOSOMES AND LIPOSOMAL DRUG DELIVERY | THE LIPOSOME COMPANY, INC. (US) | 1998-04-23 | — | — | WO | claimed |
| US-20250099625-A1 | TANDEM MOLECULAR FLUORESCENCE REPORTERS FOR DETECTION OF TUMOR-INFILTRATING LEUKOCYTES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2025-03-27 | — | — | US | disclosed |
| CN-119157801-B | Preparation method of nitraria seed extract, and product and application thereof | 云南特色植物提取实验室有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-119157801-A | Preparation method of nitraria seed extract, and product and application thereof | 云南云科特色植物提取实验室有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-119074712-A | Application of elastase inhibitor in preparation of medicine for treating cerebral hypoperfusion | 首都医科大学附属北京天坛医院 | 2024-12-06 | — | — | CN | disclosed |
| CN-119015448-A | Methods and compositions related to therapeutic peptides for cancer therapy | 芝加哥大学 | 2024-11-26 | — | — | CN | disclosed |
| CN-119031931-A | Protease 3 (PR 3) chimeric autoantibody receptor T cells and related methods and uses | 朱诺治疗学股份有限公司 | 2024-11-26 | — | — | CN | disclosed |
| CN-118286123-B | Rosa roxburghii fruit extract prepared by microbial fermentation and preparation method and application thereof | 广州君奕科技有限公司 | 2024-11-15 | — | — | CN | disclosed |
| US-6087325-A | CONJUGATE OF CERTAIN PEPTIDES TO PHOSPHATIDYLETHANOLAMINES, INCORPORATED INTO LIPOSOMES SO AS TO SELECTIVELY DESTABILIZE THE LIPOSOMES IN THE VICINITY OF TARGET PEPTIDASE-SECRETING CELLS, HENCE DELIVER THE LIPOSOMES | THE LIPOSOME COMPANY, INC. (US) | 2000-07-11 | — | — | US | disclosed |
| EP-0964690-A4 | PEPTIDE-LIPID CONJUGATES, LIPOSOMES AND LIPOSOMAL DRUG DELIVERY | LIPOSOME CO INC (US) | 2000-03-29 | — | — | EP | disclosed |
| EP-0964690-A1 | PEPTIDE-LIPID CONJUGATES, LIPOSOMES AND LIPOSOMAL DRUG DELIVERY | THE LIPOSOME COMPANY, INC. (US) | 1999-12-22 | — | — | EP | disclosed |
| WO-1998016240-A1 | PEPTIDE-LIPID CONJUGATES, LIPOSOMES AND LIPOSOMAL DRUG DELIVERY | THE LIPOSOME COMPANY, INC. (US) | 1998-04-23 | — | — | WO | disclosed |
| EP-0475160-B1 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 1996-02-14 | — | — | EP | disclosed |
| EP-0475160-A1 | Preparation for drug application in minute droplet form | Cevc, Gregor, Prof. Dr. (DE) | 1992-03-18 | — | — | EP | disclosed |
| WO-1992003122-A1 | PREPARATION FOR APPLICATION OF ACTIVE SUBSTANCES IN THE FORM OF MINIMUM-SIZED DROPLETS | CEVC GREGOR (DE) | 1992-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250099625-A1 | TANDEM MOLECULAR FLUORESCENCE REPORTERS FOR DETECTION OF TUMOR-INFILTRATING LEUKOCYTES | GZMB, GUSB, MKI67 | ELANE 181/4885XIAP 1492/4885CMA1 102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.